Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
GI Innovation, Inc.
Compass Therapeutics
Mayo Clinic
Mayo Clinic
Hoffmann-La Roche
Neonc Technologies, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Bristol-Myers Squibb
AstraZeneca
Pfizer
Duke University